Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR by Zoltowska, K, Webster, R, Finlayson, S, Maxwell, S, Cossins, J, Müller, J, Lochmüller, H, Beeson, D

Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR. by Zoltowska, K, Webster, R, Finlayson, S, Maxwell, S, Cossins, J, Müller, J, Lochmüller, H, Beeson, D

The search for new antigenic targets in myasthenia gravis. by Cossins, J, Belaya, K, Zoltowska, K, Koneczny, I, Maxwell, S, Jacobson, L, Leite, M, Waters, P, Vincent, A, Beeson, D

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14 by Cossins, J, Belaya, K, Hicks, D, Salih, M, Finlayson, S, Carboni, N, Liu, W, Maxwell, S, Zoltowska, K, Farsani, G, Laval, S, Seidhamed, M, Donnelly, P, Bentley, D, McGowan, S, Müller, J, Palace, J, Lochmüller, H, Beeson, D

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14 by Cossins, J, Belaya, K, Belaya, K, Hicks, D, Salih, M, Finlayson, S, Finlayson, S, Carboni, N, Liu, W, Maxwell, S, Zoltowska, K, Farsani, G, Laval, S, Seidhamed, M, Donnelly, P, Bentley, D, McGowan, S, Müller, J, Palace, J, Lochmüller, H, Beeson, D